HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melinda J Gooderham Selected Research

Melinda J Gooderham Research Topics

Disease

32Psoriasis (Pustulosis Palmaris et Plantaris)
03/2024 - 03/2016
21Atopic Dermatitis (Atopic Eczema)
03/2024 - 05/2017
6Acne Vulgaris
05/2024 - 01/2018
6Pruritus (Itching)
11/2023 - 11/2018
6Eczema
11/2023 - 01/2018
4Infections
04/2023 - 01/2020
3Erythema
09/2023 - 01/2020
3Neoplasms (Cancer)
04/2023 - 05/2022
2Pain (Aches)
03/2024 - 04/2021
2Asthma (Bronchial Asthma)
11/2023 - 05/2022
2Conjunctivitis
11/2023 - 01/2020
2Hidradenitis Suppurativa
07/2022 - 01/2018
2Nausea
06/2022 - 03/2017
2COVID-19
05/2022 - 01/2022
2Acrodermatitis (Gianotti Crosti Syndrome)
07/2019 - 01/2019
2Dermatitis
01/2018 - 10/2014
1Food Hypersensitivity (Food Allergy)
11/2023
1Hypersensitivity (Allergy)
11/2023
1Rhinitis
11/2023
1Thrombosis (Thrombus)
11/2022
1Herpes Simplex
06/2022
1Headache (Headaches)
06/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
06/2022
1Herpes Zoster
06/2022
1Chronic Urticaria
05/2022
1Celiac Disease (Celiac Sprue)
01/2022
1Skin Diseases (Skin Disease)
01/2021
1Psoriatic Arthritis
01/2020
1Crohn Disease (Crohn's Disease)
01/2020
1Ulcerative Colitis
01/2020
1Body Weight (Weight, Body)
01/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020
1Injection Site Reaction
01/2020
1Alopecia Areata
05/2019
1Inflammation (Inflammations)
11/2018
1Hyperostosis
01/2018

Drug/Important Bio-Agent (IBA)

9Immunoglobulin A (IgA)IBA
03/2024 - 01/2020
8RoflumilastIBA
03/2024 - 01/2020
8abrocitinibIBA
11/2023 - 12/2019
6Janus KinasesIBA
03/2024 - 01/2021
6dupilumabIBA
01/2022 - 01/2018
5Phosphodiesterase 4 InhibitorsIBA
12/2023 - 01/2020
4Janus Kinase InhibitorsIBA
03/2024 - 05/2019
4apremilastIBA
12/2023 - 03/2017
3Adapalene (Differin)FDA LinkGeneric
05/2024 - 05/2023
3clindamycin phosphate (Clindets)FDA LinkGeneric
05/2024 - 05/2023
3Benzoyl PeroxideFDA LinkGeneric
05/2024 - 05/2023
3Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
12/2023 - 03/2017
3ixekizumabIBA
01/2023 - 01/2020
3Adalimumab (Humira)FDA Link
07/2022 - 01/2018
3Interleukin-23 (Interleukin 23)IBA
08/2021 - 05/2020
3AlitretinoinFDA Link
01/2019 - 10/2014
2Anti-Bacterial Agents (Antibiotics)IBA
05/2024 - 11/2023
2RetinoidsIBA
05/2024 - 11/2023
2TYK2 Kinase (Tyrosine Kinase 2)IBA
03/2024 - 11/2022
2crisaboroleIBA
12/2023 - 01/2021
2tazarotene (Tazorac)FDA Link
09/2023 - 05/2023
2deucravacitinibIBA
01/2023 - 11/2022
2Interleukin-17 (Interleukin 17)IBA
01/2023 - 01/2020
2CytokinesIBA
01/2023 - 05/2020
2Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 01/2018
2guselkumabIBA
08/2021 - 11/2020
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 05/2017
1Clindamycin (Cleocin)FDA LinkGeneric
05/2024
1upadacitinibIBA
03/2024
1GelsIBA
05/2023
1halobetasol (ulobetasol)FDA LinkGeneric
05/2023
1InterleukinsIBA
01/2023
1ropsacitinibIBA
01/2023
1InterferonsIBA
01/2023
1Interleukin-12 (IL 12)IBA
01/2023
1LipidsIBA
11/2022
1Phosphotransferases (Kinase)IBA
11/2022
1CreatinineIBA
11/2022
1Creatine Kinase (Creatine Phosphokinase)IBA
06/2022
1Omalizumab (Xolair)FDA Link
05/2022
1VaccinesIBA
05/2022
1AerosolsIBA
03/2022
1Ointments (Pastes)IBA
03/2022
1betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
03/2022
1calcipotriene (calcipotriol)FDA LinkGeneric
03/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1Glutens (Glutelin)IBA
01/2022
1EnzymesIBA
01/2021
1Interleukin-23 Subunit p19IBA
05/2020
1risankizumabIBA
05/2020
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2020
1secukinumabIBA
01/2020
1brodalumabIBA
01/2020
1Janus Kinase 1IBA
12/2019
1Clobetasol (Clobetasol Propionate)FDA LinkGeneric
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1Prostaglandins AIBA
11/2018

Therapy/Procedure

18Therapeutics
11/2023 - 05/2017
5Biological Therapy
07/2020 - 03/2016
2Injections
01/2018 - 01/2018
1Duration of Therapy
11/2023
1Aftercare (After-Treatment)
09/2022
1Contraindications
12/2019
1Transjugular Intrahepatic Portasystemic Shunt
07/2019